Insider Transactions in Q1 2021 at Allovir, Inc. (ALVR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,750
-0.72%
|
$93,750
$25.97 P/Share
|
|
Mar 16
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,025
-0.12%
|
$90,750
$30.0 P/Share
|
|
Mar 11
2021
|
John Robert Wilson Director |
SELL
Open market or private sale
|
Indirect |
16,662
-0.09%
|
$516,522
$31.25 P/Share
|
|
Mar 10
2021
|
John Robert Wilson Director |
SELL
Open market or private sale
|
Indirect |
72,743
-0.26%
|
$2,255,033
$31.61 P/Share
|
|
Mar 09
2021
|
John Robert Wilson Director |
SELL
Open market or private sale
|
Indirect |
110,595
-0.59%
|
$3,428,445
$31.5 P/Share
|
|
Mar 05
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
48,091
-1.13%
|
$1,538,912
$32.31 P/Share
|
|
Mar 04
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
49,598
-1.38%
|
$1,785,528
$36.03 P/Share
|
|
Mar 03
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
17,915
-0.64%
|
$662,855
$37.72 P/Share
|
|
Mar 03
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
15,988
-0.23%
|
$591,556
$37.95 P/Share
|
|
Mar 02
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
512
-0.11%
|
$18,944
$37.93 P/Share
|
|
Mar 02
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
12,658
-0.45%
|
$481,004
$38.25 P/Share
|
|
Mar 02
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
14,994
-0.21%
|
$569,772
$38.23 P/Share
|
|
Mar 01
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
21,694
-1.13%
|
$824,372
$38.7 P/Share
|
|
Mar 01
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
9,518
-0.19%
|
$361,684
$38.82 P/Share
|
|
Mar 01
2021
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Indirect |
6,000
-1.52%
|
$228,000
$38.86 P/Share
|
|
Mar 01
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,932
-0.6%
|
$225,416
$38.91 P/Share
|
|
Mar 01
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
32,854
-0.46%
|
$1,248,452
$38.84 P/Share
|
|
Feb 23
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
8,489
-0.22%
|
$331,071
$39.95 P/Share
|
|
Feb 23
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,199
-0.06%
|
$163,761
$39.66 P/Share
|
|
Feb 23
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,118
-0.21%
|
$82,602
$39.75 P/Share
|
|
Feb 23
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
8,850
-0.09%
|
$345,150
$39.64 P/Share
|
|
Feb 22
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
800
-1.22%
|
$34,400
$43.14 P/Share
|
|
Feb 22
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
11,423
-0.39%
|
$479,766
$42.59 P/Share
|
|
Feb 22
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,706
-0.12%
|
$239,652
$42.19 P/Share
|
|
Feb 22
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,800
-0.28%
|
$117,600
$42.17 P/Share
|
|
Feb 22
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
14,321
-0.2%
|
$601,482
$42.59 P/Share
|
|
Feb 19
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
11,990
-1.2%
|
$491,590
$41.78 P/Share
|
|
Feb 19
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
7,541
-0.3%
|
$309,181
$41.75 P/Share
|
|
Feb 19
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,165
-0.83%
|
$170,765
$41.71 P/Share
|
|
Feb 19
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
13,233
-0.54%
|
$542,553
$41.79 P/Share
|
|
Feb 18
2021
|
Jeffrey S Bornstein |
SELL
Open market or private sale
|
Indirect |
20,583
-98.03%
|
$823,320
$40.83 P/Share
|
|
Feb 18
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
6,757
-0.22%
|
$270,280
$40.5 P/Share
|
|
Feb 18
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
8,942
-0.12%
|
$357,680
$40.47 P/Share
|
|
Feb 18
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,085
-0.14%
|
$83,400
$40.59 P/Share
|
|
Feb 18
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
741
-0.56%
|
$28,899
$39.87 P/Share
|
|
Feb 18
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,700
-0.04%
|
$108,000
$40.38 P/Share
|
|
Feb 17
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,496
-0.69%
|
$699,840
$40.11 P/Share
|
|
Feb 17
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,320
-0.85%
|
$92,800
$40.32 P/Share
|
|
Feb 17
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,286
-0.03%
|
$89,154
$39.92 P/Share
|
|
Feb 17
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
5,165
-0.13%
|
$206,600
$40.48 P/Share
|
|
Feb 17
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
7,460
-0.1%
|
$290,940
$39.99 P/Share
|
|
Feb 16
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,050
-2.14%
|
$128,100
$42.24 P/Share
|
|
Feb 16
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,100
-0.3%
|
$130,200
$42.14 P/Share
|
|
Feb 16
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,050
-0.06%
|
$128,100
$42.31 P/Share
|
|
Feb 16
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
6,220
-0.2%
|
$261,240
$42.38 P/Share
|
|
Feb 16
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
10,400
-0.21%
|
$436,800
$42.16 P/Share
|
|
Feb 02
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
54,849
-9.54%
|
$2,248,809
$41.19 P/Share
|
|
Feb 02
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
48,910
-8.74%
|
$2,005,310
$41.19 P/Share
|
|
Jan 21
2021
|
David Hallal |
BUY
Grant, award, or other acquisition
|
Direct |
147,000
+6.18%
|
-
|
|
Jan 19
2021
|
Jeroen B Van Beek Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+5.89%
|
-
|